Effects of HIV protease, nucleoside/non-nucleoside reverse transcriptase inhibitors on Bax, Bcl-2 and apoptosis in two cervical cell lines

Keyphrases

• Gene Expression 100%
• Protease Inhibitors 100%
• Apoptosis 100%
• B-cell Lymphoma 2 (Bcl-2) 100%
• Cervical Cell Lines 100%
• Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) 100%
• Nucleosides 100%
• HIV-1 Protease 100%
• AIDS/HIV 50%
• Adverse Effects 50%
• Medication Adherence 50%
• Clinical Treatment 50%
• Cervical Cancer 50%
• Regulatory Genes 50%
• Protein Synthesis 50%
• Therapeutic Efficacy 50%
• Cancer Development 50%
• Immunocytochemistry 50%
• Expression Localization 50%
• Protease 50%
• Apoptosis Induction 50%
• Antiviral Drugs 50%
• RNA Synthesis 50%
• Anti-apoptotic 50%
• Therapeutic Treatment 50%
• Cell Death Detection 50%
• Acridine Orange Staining 50%
• Reverse Transcriptase 50%
• Protein Localization 50%
• Real-time qPCR 50%
• HIV Protease Inhibitors 50%
• Oncogenicity 50%
• Highly Active Antiretroviral Therapy (HAART) 50%
• Camptothecin 50%
• Antiretroviral Agents 50%
• Gene/protein 50%
• Anti-apoptotic Effect 50%
• Bcl-2 Gene 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Proteinase Inhibitor 100%
• Antiapoptotic 100%
• High-Content Screening 100%
• Nonnucleoside Reverse Transcriptase Inhibitor 100%
• Human Immunodeficiency Virus Proteinase 100%
• Nucleoside 100%
• Malignant Neoplasm 50%
• Enzyme-Linked Immunosorbent Assay 50%
• Uterine Cervix Cancer 50%
• Proteinase 50%
• Human Immunodeficiency Virus Proteinase Inhibitor 50%
• Acridine Orange 50%
• Antiretrovirus Agent 50%
• Carcinogenicity 50%
• Acquired Immune Deficiency Syndrome 50%
• Camptothecin 50%
• Reverse Transcriptase 50%
• Adverse Effect 50%